|
|
||||||||
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Tsukuba, Ibaraki, Japan
Stimulation of human neutrophils with inflammatory
mediators such as TNF-
or platelet-activating factor (PAF) induces
translocation of adhesion molecule Mac-1 (CD11b/CD18) from secretory
vesicles to the plasma membrane. Type II phospholipase
A2 (PLA2-II) also induces translocation
of Mac-1 from secretory vesicles. However, there are more Mac-1
molecules in gelatinase granules and specific granules than in
secretory vesicles. Therefore, different combinations of
PLA2-II and other mediators were examined for their ability
to induce gelatinase granules and specific granules to induce Mac-1
surface expression. The combination of PLA2-II and PAF
synergistically increased Mac-1 surface expression, and the effect was
greater than the combinations of PLA2-II with TNF-
,
IL-8, or FMLP. Additionally, the combination of PLA2-II and
PAF induced exocytosis of both secretory vesicles and gelatinase
granules, which did not occur with either PLA2-II alone or
PAF alone. The induction was accompanied by marked production of
leukotriene B4. AA861, an inhibitor of 5-lipoxygenase, did
not inhibit exocytosis of secretory vesicles but did inhibit exocytosis
of gelatinase granules and decrease Mac-1 surface expression. It was
also found that Ca2+ influx is essential for 5-lipoxygenase
activation, because Ni2+, which blocks the influx of
extracellular Ca2+, inhibited the production of leukotriene
B4. These results suggest that stimulation by the
combination of PLA2-II and PAF, unlike stimulation by each
mediator alone, causes exocytosis of gelatinase granules via the
5-lipoxygenase pathway, resulting in a synergistic increase in
neutrophil Mac-1 surface expression during inflammatory processes.
This article has been cited by other articles:
![]() |
H. W.M Niessen, P. A.J Krijnen, C. A Visser, C. J.L.M Meijer, and C Erik Hack Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovasc Res, October 15, 2003; 60(1): 68 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gabrijelcic, A. Acuna, M. Profita, A. Paterno, K.F. Chung, A.M. Vignola, and R. Rodriguez-Roisin Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Eur. Respir. J., August 1, 2003; 22(2): 290 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Triggiani, F. Granata, A. Oriente, V. De Marino, M. Gentile, C. Calabrese, C. Palumbo, and G. Marone Secretory Phospholipases A2 Induce {beta}-Glucuronidase Release and IL-6 Production from Human Lung Macrophages J. Immunol., May 1, 2000; 164(9): 4908 - 4915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Anthonsen, A. Solhaug, and B. Johansen Functional Coupling between Secretory and Cytosolic Phospholipase A2 Modulates Tumor Necrosis Factor-alpha - and Interleukin-1beta -induced NF-kappa B Activation J. Biol. Chem., August 3, 2001; 276(32): 30527 - 30536. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |